Bausch + Lomb buys JNJ's dry eye drops for $106.5M in expansion of OTC business
Keytruda keeps racking up approvals and clinical wins in 2023
Pfizer pours $25M investment into Caribou's cell therapies
Medtech dealmaking grinds almost to a halt
*please scroll down for all the latest news*
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraudimage: 
Original Article
July 6 2023 – Bausch + Lomb buys JNJ’s dry eye drops for $106.5M in expansion of OTC business
